Comparing Tamsulosin and Solifenacin for Relieving Double J Stent Symptoms: Using the USSQ.
Status:
COMPLETED
Trial end date:
2025-03-30
Target enrollment:
Participant gender:
Summary
This study evaluates the effects of two medications-tamsulosin and solifenacin-on symptoms associated with double J (DJ) ureteral stents. The research is conducted among patients undergoing unilateral DJ stent placement for ureteric calculi or post-ureteroscopic lithotripsy. Participants are randomly assigned to receive either tamsulosin or solifenacin, and symptom severity is assessed using the Ureteral Stent Symptom Questionnaire (USSQ).